Literature DB >> 17085272

A survey of pain in idiopathic Parkinson's disease.

Mark A Lee1, Richard W Walker, Tony J Hildreth, Wendy M Prentice.   

Abstract

The aim of this study was to use both quantitative and qualitative data to assess pain in idiopathic Parkinson's disease (IPD) and classify it according to cause. In this descriptive cross-sectional study, 123 patients were interviewed and pain was assessed using patient descriptions, the Brief Pain Inventory, and Visual Analogue Scales. Patients reported 285 pains (median 2 per patient), and 22.8% had 4 or more pains. Pain was reported as a problem in 85% and was IPD-related in 62.6% of patients, unrelated to IPD in 64.2%, indirectly related to IPD in 8.1%, related to multiple causes in 4.1%, and treatment related in 0.8%. Pain unrelated to IPD was more common, more constant, and more severe than IPD-related pain. Overall, analgesic use was low. This study demonstrates the benefits of adopting a systematic and logical approach to the assessment of pain in IPD and the merits of a simple new classification system.

Entities:  

Mesh:

Year:  2006        PMID: 17085272     DOI: 10.1016/j.jpainsymman.2006.05.020

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  41 in total

1.  The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

Authors:  B Isomaa; G Sjöblom
Journal:  Food Cosmet Toxicol       Date:  1975-10

2.  Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue.

Authors:  Hong-Bo Wen; Zhen-Xin Zhang; Han Wang; Ling Li; Honglei Chen; Yiming Liu; Baorong Zhang; Qun Xu
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

3.  Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis.

Authors:  Colin W Campbell; Edward J S Jones; Jane Merrills
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

4.  The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

Authors:  James Shearer; Colin Green; Carl E Counsell; John P Zajicek
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

Review 5.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

Review 6.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

7.  Deep brain stimulation significantly decreases disability from low back pain in patients with advanced Parkinson's disease.

Authors:  Heather Smith; Lucy Gee; Vignessh Kumar; Adolfo Ramirez-Zamora; Jennifer Durphy; Era Hanspal; Anne Barba; Eric Molho; Damian Shin; Julie G Pilitsis
Journal:  Stereotact Funct Neurosurg       Date:  2015-04-21       Impact factor: 1.875

Review 8.  Palliative care and end-of-life planning in Parkinson's disease.

Authors:  Richard William Walker
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

9.  Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients.

Authors:  Eliezer Golan; Isabelle Haggiag; Pnina Os; Jacques Bernheim
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

Review 10.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.